Page 833 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

VetBooks.ir Index

A Acute myeloid leukemia, canine, 732–734, Adoptive T-cell transfer (ACT), 241–242
AA. see Arachidonic acid 733f, 734t methods for
17-AAG, 271 treatment, 738 lymphodepletion, 241–242
AAs. see Acanthomatous ameloblastoma Acutely transforming oncovirus, 43 lymphokine-activated killer cell transfer,
AAV. see Adeno-associated virus Adaptive trial design, 346 241–242
ABC transporter family, 185–186 Bayesian approach to, 346–347 tumor-infiltrating lymphocytes transfer,
ABCs. see Aneurysmal bone cysts ADCC. see Antibody-dependent cell-mediated 242
Abdomen, laparoscopic and thoracoscopic cytotoxicity Adrenal cortical tumor, 137
biopsy of, 161 Adeno-associated virus (AAV), 252t Adrenal-dependent hypercortisolism (ADH),
Abdominal radiographs, for intestinal tumors, Adenocarcinoma, 461–462, 461f 566
463–464 prostatic, 631 Adrenal gland neoplasia, 571–575
Abl gene, 11–12 risk factors for, 631 Adrenal masses, incidental, 575
Ablative technique as uterine tumors, 600 Adrenal medullary tumors, 573–574
indications/limitations of, 169 Adenoma, 63 Adrenal tumors, surgical management of,
types of Adenomatous polyp, 461–462 574–575
cryoablation, 169 Adenosine, 233 Adrenalectomy
radiofrequency, 169 Adenosine monophosphate (AMP), 233 for adrenal tumors, 574
Absorbed dose, 209 Adenosine triphosphate (ATP)-binding for feline adrenocortical tumors, 573
ABT-510, 264 cassette (ABC) transporter family, 197 for incidental adrenal masses, 575
ABT-526, 264 Adenoviral vector, 252f Adrenocortical tumors
Acanthomatous ameloblastoma (AAs), 435 Adenovirus, 252t canine, 572–573
prognosis of, 445 conditionally replicating, 254, 254f feline, 573
radiation therapy for, 218 ADH. see Adrenal-dependent hypercortisolism Adrenocorticotropic hormone (ACTH)
rim resection of, 440f Adipose tissue tumors, 407–408 ectopic production of, 102
Accelerated repopulation, of tumor cells, cell characteristics in, 139 pituitary tumors and, 565
211–212 infiltrative lipoma, 407–408, 407f stimulation test of, in adrenal tumors, 575
ACD. see Anemia of chronic disease intermuscular lipoma, 407, 407f Aerosol drug delivery, for gross metastatic
Acetaminophen lipoma, 407 disease, 546–547
dose and effects of liposarcoma, 408, 408f AFP. see Alpha fetoprotein
for cats, 293t–294t Adjuvant carboplatin chemotherapy, for Age, tumor-related prognosis and, 164
for dogs, 292t canine osteosarcoma, 539 AgNOR. see Argyrophilic nucleolar organizer
for pain management, 290 Adjuvant chemotherapy, definition of, 183 region
ACI. see Animal Clinical Investigation Adjuvant therapy, systemic, for canine Aldosterone-secreting adrenocortical tumors,
Acrolein, 15 osteosarcoma, 542–545 572–573
Acromegaly, 101–102 chemotherapy in, 542–544, 543t Alimentary lymphoma, 718–723, 719t
feline, 569–571, 570f conventional chemotherapy combined with diagnosis and clinical staging, 720–721
Acrylic face mask, 215–216, 216f metronomic therapies in, 544 intermediate- or high-grade alimentary
ACT. see Adoptive T-cell transfer doxorubicin-carboplatin alternating lymphoma and large granular
ACTH. see Adrenocorticotropic hormone chemotherapy in, 543 lymphoma, 721
Actin cytoskeleton, 53 doxorubicin-carboplatin combined low-grade alimentary lymphoma,
Actinic keratosis, 357 chemotherapy in, 542–543 720–721
Actinomycin D (dactinomycin), 193 doxorubicin-carboplatin modified history, clinical signs, and physical
Activating gene, prodrug cancer gene therapy combination sequencing or dose examination findings, 720
and, 255f interval in, 543–544 intermediate- or high-grade alimentary
Active immune suppression, 233 head-to-head comparison studies in, 544 lymphoma, 720
Active vitamin D, 309 immunotherapy in, 544–545 large granular lymphoma, 720
Acupuncture single-agent carboplatin chemotherapy in, low-grade alimentary lymphoma, 720
benefit of, 331 542 pathology and natural behavior, 718–720
in integrative oncology, 331 single-agent doxorubicin chemotherapy in, intermediate- or high-grade alimentary
for pain management, 298 542 lymphoma, 720
risks of, 331 Adnexal tumor, 675 large granular lymphoma, 720
Acute myelogenous leukemia (AML), tumor- differentiating, 132–133 low-grade alimentary lymphoma,
initiating cell hypothesis and, 10–11 incidence of, 678 718–720
Note: Page numbers followed by “f” indicate figures, “t” indicate tables and “b” indicate boxes.

811